Edition:
United States

Nevro Corp (NVRO.N)

NVRO.N on New York Stock Exchange

58.90USD
24 Sep 2018
Change (% chg)

-- (--)
Prev Close
$58.90
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
123,473
52-wk High
$94.32
52-wk Low
$35.55

Chart for

About

Nevro Corp. is a global medical device company. The Company focuses on providing products that improve the quality of life of patients suffering from chronic pain. The Company has developed and commercialized the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic... (more)

Overall

Beta: -0.70
Market Cap(Mil.): $1,773.82
Shares Outstanding(Mil.): 30.12
Dividend: --
Yield (%): --

Financials

  NVRO.N Industry Sector
P/E (TTM): -- 39.60 32.55
EPS (TTM): -1.30 -- --
ROI: -9.97 14.06 12.80
ROE: -15.99 17.32 14.92

BRIEF-Nevro Reports Qtrly Loss Per Share $0.59

* REITERATES ITS EXPECTATIONS FOR WORLDWIDE REVENUE FOR 2018 TO BE IN RANGE OF $400 TO $410 MILLION

May 07 2018

BRIEF-Nevro Corp Says CEO Rami Elghandour's FY 2017 Total Compensation Was $13.2 Mln

* NEVRO CORP SAYS CEO RAMI ELGHANDOUR'S FY 2017 TOTAL COMPENSATION WAS $13.2 MLN VS $11.5 MLN IN FY 2016 - SEC FILING Source text: [https://bit.ly/2GEJ7Jw] Further company coverage:

Apr 06 2018

Earnings vs. Estimates